A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence
The past decade has seen the increasing influence and relevance of real-world data (RWD) and real-world evidence (RWE) in healthcare decision making. The value added by RWD/RWE has prompted the pharmaceutical industry to develop high performing systems and practices to harness the power of evidence...
Main Authors: | Kristoffer Larsen, Ryan N. Walton, Mohamed Elsayed, Andrey Ipatov, Faye Townsend-Holyoake, Sebastian F. A. Axelsson, Nacho Quinones, Rudiger Papsch, Jennifer Givens, Alexander Bedenkov, Michael Seewald |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1233617/full |
Similar Items
-
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
by: Hideki Maeda, et al.
Published: (2022-04-01) -
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
by: Patrick Maison, et al.
Published: (2022-07-01) -
The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022-10-01) -
Real-world data: a brief review of the methods, applications, challenges and opportunities
by: Fang Liu, et al.
Published: (2022-11-01) -
Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
by: Hun-Sung Kim, et al.
Published: (2018-12-01)